In Vitro and In Silico Evaluation of the Potential Anti-Prostate Cancer Activity of L. Leaf Extracts.

Prostate cancer is one of the most prevalent cancer types diagnosed in older men. Investigations into traditional medicines like L., popularly known as rosemary, are a current research interest due to its anti-cancer properties. This study investigates the cytotoxicity of aqueous and ethanolic rosemary leaf extracts in DU-145 cells and the interaction of its active metabolites with key prostate cancer targets using an in silico approach. The water extract of rosemary leaves showed greater cytotoxicity than the ethanol extract, with IC values of 1.4140 ± 0.1138 mg/mL and 1.8666 ± 0.0367 mg/mL, respectively; the highest cytotoxic effects for both extracts were observed at 5 mg/mL. These findings indicate significant cytotoxic differences based on concentration and solvent. Network pharmacology identified 37 genes linked to prostate adenocarcinoma, highlighting key genes like , , , , , , , , and . Molecular dynamics simulations and binding energy calculations revealed strong interactions between carnosol and rosmarinic acid with these targets, with TP53-carnosol showing the most stable conformation. Rosmarinic acid was identified as a promising candidate due to its low toxicity. This study demonstrates the potential anti-prostate cancer properties of rosemary leaf extracts for further investigations on the development of drugs against prostate cancer.